dc.contributor.author
Vieta i Pascual, Eduard, 1963-
dc.contributor.author
Oliva, Vincenzo
dc.date.issued
2025-10-23T15:47:35Z
dc.date.issued
2025-05-22
dc.date.issued
2025-10-23T15:47:35Z
dc.date.issued
info:eu-repo/date/embargoEnd/2026-05-21
dc.identifier
https://hdl.handle.net/2445/223860
dc.description.abstract
In recent years, growing scientific attention has converged on the intricate, bidirectional relationship between physical health and mental well-being. Chronic inflammation, disruptions in the gut–brain axis and microbiota, and metabolic alterations such as obesity and type 2 diabetes have all been implicated in the pathophysiology of neuropsychiatric disorders. These insights are not merely academic—they are transforming how we approach, frame, and treat neuropsychiatric disorders.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2025.05.006
dc.relation
European Neuropsychopharmacology, 2025, vol. 97, p. 3-4
dc.relation
https://doi.org/10.1016/j.euroneuro.2025.05.006
dc.rights
cc-by-nc-nd (c) Elsevier B.V., 2025
dc.rights
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/embargoedAccess
dc.source
Articles publicats en revistes (Medicina)
dc.subject
Malalties mentals
dc.subject
Hormones gastrointestinals
dc.subject
Humor (Psicologia)
dc.subject
Mental illness
dc.subject
Gastrointestinal hormones
dc.subject
Mood (Psychology)
dc.title
Thinner and wiser? Prospects of GLP-1 agonists in psychiatry
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion
